DBVT Q3 2021 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$1M

Operating Income

-$26M

Net Income

-$24M

EPS (Diluted)

$-2.20

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$171M

Total Liabilities

$54M

Stockholders' Equity

$117M

Cash & Equivalents

$98M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$4M	-100.0%
Gross Profit	-$1M	$4M	-126.0%
Operating Income	-$26M	-$30M	+14.0%
Net Income	-$24M	-$31M	+22.6%